DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 020752
The generic ingredient in PEPCID RPD is famotidine. There are eighteen drug master file entries for this compound. One hundred and nine suppliers are listed for this compound. Additional details are available on the famotidine profile page.
Summary for 020752
Tradename: | PEPCID RPD |
Applicant: | Merck |
Ingredient: | famotidine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 020752
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 20MG | ||||
Approval Date: | May 28, 1998 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, ORALLY DISINTEGRATING;ORAL | Strength | 40MG | ||||
Approval Date: | May 28, 1998 | TE: | RLD: | No |
Expired US Patents for NDA 020752
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | PEPCID RPD | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 020752-001 | May 28, 1998 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Merck | PEPCID RPD | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 020752-002 | May 28, 1998 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Merck | PEPCID RPD | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 020752-002 | May 28, 1998 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Merck | PEPCID RPD | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 020752-002 | May 28, 1998 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Merck | PEPCID RPD | famotidine | TABLET, ORALLY DISINTEGRATING;ORAL | 020752-001 | May 28, 1998 | ➤ Try a Free Trial | ➤ Try a Free Trial |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Complete Access Available with Subscription